ID significantly reduced DNFB-induced dermatitis and decreased the serum levels of IgE and the IL-1β via the inhibition of p38, ERK, and JNK phosphorylation as well as the activation of NF-κB in AD-like skin lesions (Fig. 1 and 2). This evidence concerns the gene NFKB1 and skin disorder.